Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
COVID-19
•
General Rheumatology
•
Infectious Disease
How do you counsel immunosuppressed patients regarding a third Covid vaccination dose if they have had 2 doses of mRNA vaccine and either pre or post vaccine Covid infection?
Related Questions
How would you treat an asymptomatic patient with a positive Blastomyces antibody, evidence of prior granulomatous lung disease on imaging, and who may require immunosuppression in the future?
How do you approach management of DMARDs and biologics in a patient with active RA, but frequent recurrent simple UTIs?
How often do you see bony erosions in patients with Lyme arthritis?
Is there a risk of hepatitis C activation with rituximab in a patient who has a history of HCV treated with antivirals and who is in sustained viral response?
Would you use the pneumococcal conjugate-21 vaccine (Capvaxive) instead of the conjugate-20 (Prevnar-20) for routine vaccinations in immunosuppressed patients?
Should patients starting cyclophosphamide be screened routinely for latent tuberculosis (TB)?
Are there any concerns with live vaccine innoculation and patients who are on denosumab?
Can inflammatory arthritis develop in patients with a history of chronic hepatitis B?
In light of recent measles outbreaks, have you adjusted your vaccination counseling or preventive strategies for adult immunocompromised patients?
How long do you recommend that a patient wear a mask when resuming biologic infusions following a recent upper respiratory infection?
